Metraipolis › archive › dc_9ecee66399cc

Ribitoborate Synergism with Histone Deacetylase Inhibitor Romidepsin as a Potential Treatment for Breast Cancer — Europe PMC PMID:42794462

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42794462
DOI
10.3390/ijms27188033
License (as archived)
solo-consultazione
Archived
2026-10-15T20:46:21.661Z
SHA-256 of the archived text
16b03c3424f86b0c4bda51113dead02caef729dfc35c31d5e1f9406420e67646
Stable URL of this page
https://metraipolis.com/documento/dc_9ecee66399cc

How to cite

Ribitoborate Synergism with Histone Deacetylase Inhibitor Romidepsin as a Potential Treatment for Breast Cancer — Europe PMC PMID:42794462 — Europe PMC (en), https://europepmc.org/article/MED/42794462 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9ecee66399cc (Metraipolis archive dc_9ecee66399cc, sha256 16b03c3424f86b0c4bda51113dead02caef729dfc35c31d5e1f9406420e67646)
BibTeX
@misc{dc9ecee66399cc,
  title = {Ribitoborate Synergism with Histone Deacetylase Inhibitor Romidepsin as a Potential Treatment for Breast Cancer — Europe PMC PMID:42794462},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42794462},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9ecee66399cc; sha256 16b03c3424f86b0c4bda51113dead02caef729dfc35c31d5e1f9406420e67646},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794462. Agents can read the archived copy with the MCP tool read_document.